UNCY Unicycive Therapeutics, Inc.
Nasdaq · SEC CIK 1766140 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 57 since 2021-07-26, latest 2026-07-28 16:15
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| No open-market trades in the last year. | |||
Transactions 9
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-08-26 | 2025-08-25 | UNCY | Aggarwal Gaurav | Dir | C - Cnv Deriv | — | +652.9K | 1.79M | +57% | — |
| DI | 2025-02-19 | 2025-02-18 | UNCY | Aggarwal Gaurav | Dir | C - Cnv Deriv | — | +1.40M | 11.37M | +14% | — |
| DI | 2024-10-10 | 2024-10-09 | UNCY | Aggarwal Gaurav | Dir | C - Cnv Deriv | — | +5.50M | 9.97M | +123% | — |
| D | 2023-07-13 | 2023-07-11 | UNCY | Gupta Shalabh K. | CEO, Dir | M - OptEx | — | +104.6K | 2.53M | +4% | — |
| D | 2023-07-13 | 2023-07-11 | UNCY | Jermasek Douglas | EVP of Corp. Strategy | M - OptEx | — | +104.6K | 175.0K | +149% | — |
| D | 2023-07-13 | 2023-07-11 | UNCY | Gupta Pramod | EVP, Pharmaceuticals, BD | M - OptEx | — | +41.8K | 41.8K | New | — |
| DI | 2023-07-13 | 2023-07-11 | UNCY | Aggarwal Gaurav | Dir | C - Cnv Deriv | — | +3.47M | 3.47M | New | — |
| D | 2022-08-30 | 2022-07-15 | UNCY | Schiller Brigitte | Dir | M - OptEx | $0.00 | +26.7K | 26.7K | New | $0 |
| 2022-05-17 | 2022-05-16 | UNCY | Schiller Brigitte | Dir | P - Purchase | $0.83 | +15.0K | 15.0K | New | +$12.4K |
Purchase Sale Sale after option exercise All abbreviations